SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Opiant Pharmaceuticals Q1 EPS $(0.400) Misses $(0.180) Estimate, Sales $4.300M Miss $4.850M Estimate

Opiant Pharmaceuticals (NASDAQ:OPNT) reported quarterly losses of $(0.400) per share which missed the analyst consensus estimate of $(0.180) by 122.22 percent. The company reported quarterly sales of $4.300 million

Benzinga · 05/12/2020 20:12

Opiant Pharmaceuticals (NASDAQ:OPNT) reported quarterly losses of $(0.400) per share which missed the analyst consensus estimate of $(0.180) by 122.22 percent. The company reported quarterly sales of $4.300 million which missed the analyst consensus estimate of $4.850 million by 11.34 percent.